Keywords: hemispherx, alferon, injection, top, anti-sars-cov, study, usa-based

Hemispherx' Alferon Injection on top in anti-SARS-CoV study

Article | 26 April 2004

Print This

USA-based Hemispherx Biopharma has reported that results of an independent study, carried out by the Genome Institute of Singapore and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in